Stay updated with breaking news from Henrik Luessen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Proceeds to support continued platform scaling, progress therapeutic leads toward preclinical proof of concept -- Sapreme, a biotechnology company focused on improving the delivery and efficacy
Sapreme Appoints Henrik Luessen as Chief Business Officer Sapreme, a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutics, today announced the appointment of Henrik L. Luessen, Ph.D., as Chief Business Officer. In this role, Dr. Luessen will advise Sapreme in its business development, partnerships and funding activities, and will report to Guy Hermans, Ph.D., Chief Executive Officer. "Henrik brings strong experience with emerging biotechnology companies to Sapreme including licensing, portfolio strategy, financing and strategic development whi...